Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2015. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3027576018 | Paliperidone palmitate | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3027593018 | Paliperidone palmitate (substance) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3741171000052119 | paliperidonpalmitat | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Paliperidone palmitate | Is a | Paliperidone (substance) | false | Inferred relationship | Some | ||
Paliperidone palmitate | Is a | Benzisoxazole derivative | true | Inferred relationship | Some | ||
Paliperidone palmitate | Is a | Substance with dopamine receptor D2 antagonist mechanism of action | true | Inferred relationship | Some | ||
Paliperidone palmitate | Has disposition (attribute) | Dopamine receptor D2 antagonist | true | Inferred relationship | Some | ||
Paliperidone palmitate | Is modification of (attribute) | Paliperidone (substance) | true | Inferred relationship | Some | ||
Paliperidone palmitate | Is a | Anti-psychotic agent (substance) | true | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Product containing precisely paliperidone (as paliperidone palmitate) 200 milligram/1 milliliter prolonged-release suspension for injection (clinical drug) | Has precise active ingredient | True | Paliperidone palmitate | Inferred relationship | Some | 1 |
This concept is not in any reference sets